FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 308:349-353 February 17, 1983 Number 7 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Beta-endorphin is present in the endocrine pancreas, suggesting that endorphins may have a role in islet-cell function. To evaluate this possibility, we infused synthetic human beta-endorphin intravenously in healthy volunteers and in insulin-dependent diabetic patients. In both groups, beta-endorphin increased plasma glucagon concentrations, and this rise was accompanied by a significant increase in plasma glucose concentrations. In nondiabetic subjects, beta-endorphin also increased plasma insulin concentrations. The threshold dose of beta-endorphin for producing increased plasma concentrations of glucose and glucagon was 0.005 mg--a dose that acutely increased plasma concentrations of beta-endorphin by approximately 40-fold. Glucose, glucagon, and insulin responses to beta-endorphin could not be blocked by intravenous naloxone. These studies suggest that endorphins may be involved in gluco-regulation, that their hyperglycemic action is mediated at least in part by glucagon, and that the effect of beta-endorphin on islet-cell function is relatively resistant to naloxone.

This article has been cited by other articles:

• Cheng, J.-T., Huang, C.-C., Liu, I-M., Tzeng, T.-F., Chang, C. J. (2006). Novel Mechanism for Plasma Glucose-Lowering Action of Metformin in Streptozotocin-Induced Diabetic Rats. Diabetes 55: 819-825 [Abstract] [Full Text]  
• Li, Y., Eitan, S., Wu, J., Evans, C. J., Kieffer, B., Sun, X., Polakiewicz, R. D. (2003). Morphine Induces Desensitization of Insulin Receptor Signaling. Mol. Cell. Biol. 23: 6255-6266 [Abstract] [Full Text]  
• Moeniralam, H. S., Endert, E., Ackermans, M. T., Van Lanschot, J. J. B., Sauerwein, H. P., Romijn, J. A. (1998). The opiate sufentanil alters the inflammatory, endocrine, and metabolic responses to endotoxin in dogs. Am. J. Physiol. Endocrinol. Metab. 275: E440-E447 [Abstract] [Full Text]